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Genetic factors underlie a substantial proportion of individual differences in cognitive
functions in humans, including processes related to episodic and working memory.
While genetic association studies have proposed several candidate “memory genes,”
these currently explain only a minor fraction of the phenotypic variance. Here, we
performed genome-wide screening on 13 episodic and working memory phenotypes in
1318 participants of the Berlin Aging Study II aged 60 years or older. The analyses highlight
a number of novel single nucleotide polymorphisms (SNPs) associated with memory
performance, including one located in a putative regulatory region of microRNA (miRNA)
hsa-mir-138-5p (rs9882688, P-value = 7.8 ×10−9). Expression quantitative trait locus
analyses on next-generation RNA-sequencing data revealed that rs9882688 genotypes
show a significant correlation with the expression levels of this miRNA in 309 human
lymphoblastoid cell lines (P-value = 5 × 10−4). In silico modeling of other top-ranking
GWAS signals identified an additional memory-associated SNP in the 3’ untranslated
region (3′ UTR) of DCP1B, a gene encoding a core component of the mRNA decapping
complex in humans, predicted to interfere with hsa-mir-138-5p binding. This prediction
was confirmed in vitro by luciferase assays showing differential binding of hsa-mir-138-5p
to 3′ UTR reporter constructs in two human cell lines (HEK293: P-value = 0.0470;
SH-SY5Y: P-value = 0.0866). Finally, expression profiling of hsa-mir-138-5p and DCP1B
mRNA in human post-mortem brain tissue revealed that both molecules are expressed
simultaneously in frontal cortex and hippocampus, suggesting that the proposed
interaction between hsa-mir-138-5p and DCP1B may also take place in vivo. In summary,
by combining unbiased genome-wide screening with extensive in silico modeling, in vitro
functional assays, and gene expression profiling, our study identified miRNA-138 as a
potential molecular regulator of human memory function.
Keywords: genome-wide association study, GWAS, working memory, episodic memory, microRNA,
hsa-mir-138-5p, DCP1B
INTRODUCTION
Interindividual variations of memory performance in humans are
regulated by genetic and non-genetic factors. Early estimates from
twin studies suggest that approximately half of the phenotypic
variance is attributable to heritable factors, while the remainder
reflects shared and non-shared environmental factors (McClearn
et al., 1997). These estimates have since received broad support
from studies using different designs and analysis approaches (for
recent review see Goldberg Hermo et al., 2014). For measures of
general cognitive ability, the presumed genetic effects appear to
increase across the lifespan, that is, from childhood to adulthood
and late life (McClearn et al., 1997), suggesting that searching for
genes in this domain may be most powerful in data sets of aged
individuals (see also Lindenberger et al., 2008).
A number of candidate genes that may affect various aspects
of memory performance in humans have been proposed to date
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(for review see Papassotiropoulos and de Quervain, 2011). As is
the case for many other genetically complex traits in humans, the
most convincing of these have only recently emerged in the con-
text of genome-wide association studies (GWAS; see NHGRI’s
“GWAS catalog” for an up-to-date overview; URL: http://www.
genome.gov/gwastudies/; Welter et al., 2014). Among the most
prominent findings are common polymorphisms (i.e., single
nucleotide polymorphisms [SNPs]) inWWC1 (WW and C2 con-
taining 1, a.k.a. KIBRA for kidney and brain expressed protein;
Papassotiropoulos et al., 2006) and CTNNBL1 (catenin, beta like
1).WWC1 is located on chromosome (chr) 5q34 and was identi-
fied nearly a decade ago in a GWAS on episodic memory in ∼300
subjects in which the lead SNP (rs17070145) showed evidence
for genome-wide significant association (Papassotiropoulos et al.,
2006). Since the original study, a number of follow-up studies
have been published, albeit with mixed results (Milnik et al.,
2012). The other lead “memory gene,” CTNNBL1 (located on
chr 20q11.23) was identified by the same group in a more
recent GWAS (Papassotiropoulos and de Quervain, 2011). Thus,
far, no reports have been published confirming this latter find-
ing independently. In addition, a number of other candidate
genes have been tested in non-GWAS association studies, some
suggesting evidence for an increased effect sizes when compar-
ing older vs. younger adults (Li et al., 2013; Papenberg et al.,
2014).
A second—and thus far largely independent—line of genetic
experiments suggests thatmemory performance, and likely a large
number of other cognitive domains, may be influenced by the
action of microRNAs (miRNAs). MiRNAs are short (i.e., typ-
ically between 18 and 24 nucleotide long), non-coding RNA
molecules that are involved in regulating protein expression
post-transcriptionally. This is achieved by binding to the target
messenger-RNAs (mRNAs), thereby directly or indirectly inter-
fering with mRNA translation. The last decade of research has
shown that miRNAs are involved in a broad range of cellular
functions, including the development, differentiation, prolifer-
ation, apoptosis, and metabolism of neurons and many other
cell types in humans (Satoh, 2012). Some estimates suggest that
the expression of up to 50% of all human proteins may be
affected by the action of one or more of the >2500 miRNAs
currently believed to exist (URL: http://mirbase.org/index.shtml;
Griffiths-Jones et al., 2006). One important factor determining
the extent of miRNA-mediated expressional regulation is the
binding affinity between miRNAs and their target mRNAs. This
is largely influenced by sequence complementarity between the
respective interacting regions on both molecules (Peterson et al.,
2014). Naturally occurring DNA sequence variants, e.g., trait
associated SNPs, within the binding domains of either of these
interactants can thus be expected to interfere with miRNA-to-
mRNA binding either by decreasing (disruption of complemen-
tary sites) or increasing (creation of complementary sites) binding
affinity.
In this study, we specifically searched for memory-associated
DNA sequence variants predicted to affect miRNA-to-mRNA
binding using a similar strategy as described previously by our
group (Lill et al., 2014). Genetic associations, with measures of
both working and episodic memory functions were assessed via
genome-wide screening as part of an ongoing GWAS in partic-
ipants of the Berlin Aging Study II (BASE-II). Associated SNPs
were evaluated for their potential effects on miRNA-to-mRNA
binding in silico using a bioinformatic prediction tool devel-
oped by our group. SNPs showing association with memory
performance and predicted to directly alter miRNA-to-mRNA
binding were further followed up using a range of in vitro
experiments involving luciferase reporter assays in two human
cell lines, as well as miRNA and mRNA expression profiling
in human brain autopsy material from three adult individ-
uals. Our analyses uncovered three memory-associated SNPs
which potentially manifest their molecular effects by interfer-
ing with miRNA function. Intriguingly, two of these SNPs,
by independent mechanisms, affect hsa-mir-138-1, a miRNA
long known to be crucial in CNS development and func-
tion in mammals (Miska et al., 2004; Siegel et al., 2009) but
hitherto not specifically linked to cognitive performance in
humans.
METHODS
GENOME-WIDE ASSOCIATION STUDY (GWAS) OF EPISODIC AND
WORKING MEMORY PERFORMANCE IN HUMANS
Participants
All GWAS participants were part of the Berlin Aging Study
II (BASE-II), a multidisciplinary project investigating factors
involved in “healthy” vs. “unhealthy” aging (Bertram et al.,
2013). In addition to genetics, BASE-II covers a broad range
of functional domains critical for understanding aging investi-
gated in a multidisciplinary assessment protocol that includes
measures from internal medicine, immunology, psychology, as
well as sociology and economics. The behavioral test battery
applied to each BASE-II participant includes an extensive cov-
erage of cognitive abilities, including detailed assessments of
working and episodic memory. At baseline, BASE-II includes
2200 participants of Caucasian ancestry recruited from the
greater Berlin area. The cohort is split into a subgroup of 1600
older adults aged 60–80 years, mean 66.76 years at baseline,
and 600 younger adults aged 20–35 years, mean 27.32 years.
Both groups consist of equal numbers of males and females.
The analyses presented here are limited to participants of the
“old” stratum for whom genotype and cognitive data were
available at the time of analysis (n = 1318). Written consent
was provided by all BASE-II individuals before participation.
The study was approved by the institutional review boards of
each relevant participating research unit prior to participant
recruitment.
Assessment of memory performance
This study is based on 13 different quantitative measures (i.e.,
2 and 11, respectively) of working memory (WM) and episodic
memory (EM) were selected, assessed either at the Center for
Lifespan Psychology at the Max Planck Institute for Human
Development (MPIHD; n = 1318 individuals with cognitive test-
ing completed at time of analysis) or at the Charité Research
Group on Geriatrics (CRGG; n = 961 with cognitive testing
completed at time of analysis) at Charité University Hospital.
At MPIHD, six participants from the same age group were
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tested simultaneously in two separate group sessions 1 week
apart. In addition, we utilized test results from the CERAD Plus
battery (Morris et al., 1989; Fillenbaum et al., 2008), which
was carried out individually to each participant at CRGG. See
Supplementary Table 1 and Supplementary Methods for more
detailed information on the type of WM and EM assessments
used here.
Genotyping and genetic association analyses
Details on genotyping and analysis procedures can be found in the
Supplementary Methods. In brief, DNA from all BASE-II partici-
pants was extracted from whole blood using standard procedures
and then subjected to microarray-based SNP genotyping using
the “Genome-Wide Human SNP Array 6.0” (Affymetrix, Inc.),
followed by an extensive quality control and genome-wide impu-
tation of unobserved genotypes using whole genome sequence
data from the 1000 Genomes Project (Abecasis et al., 2010).
Association analyses were carried out using the EM or WM vari-
ables as quantitative traits assuming an additive linear model,
adjusted for age, sex, and years of education and to the first three
principal components to account for potential population strat-
ification. Association analyses were performed using SNPTEST
v.1.3 (Marchini and Howie, 2010), which accounts for uncer-
tainty of imputed genotype calls via missing data likelihood tests.
Overall, in this study we tested a total of 12,607,232 high-quality
SNPs for genetic association with the memory traits in 1318
(MPIHD) and 961 (CRGG) subjects from the BASE-II subgroup
aged 60–80 years.
IN SILICO PREDICTIONS OF miRNA-TO-mRNA BINDING AND
POTENTIAL SNP EFFECTS
To systematically assess the potential impact of SNP allele-
status on miRNA-to-mRNA binding, we utilized a bioinformatic
tool recently developed by our group described in detail else-
where (Schilling, 2011, 2013). In brief, this entailed a predic-
tion of potential miRNA binding sites for 3′UTRs of all known
protein-coding transcripts (downloaded from Ensembl Genes
71, http://www.ensembl.org/biomart/martview) using miRanda
v.3.38, TargetScan 5.09 and PITA and v19 of the mirBASE
database (http://www.mirbase.org). Only SNPs displaying strong
linkage disequilibrium (LD; i.e., r2 of 0.8; estimated from whole
genome sequence data of the 1000 Genomes phase 1 CEU refer-
ence panel; Abecasis et al., 2010) with GWAS SNPs were consid-
ered further. For these SNPs, we finally estimated the potential
effects on miRNA-to-mRNA binding using a modified version of
the support vector regression (SVR) method developed by Betel
(Betel et al., 2010).
IN VITRO ASSESSMENT OF SNPs PREDICTED TO AFFECT
miRNA-TO-mRNA BINDING
Cell culture and construct transfection
Experiments were performed as previously described (Lill et al.,
2014). Custom made reporter plasmids (pLightSwitch_3UTR)
containing the appropriate 3′UTR sequence and the miRNA
mimics were purchased from SwitchGear Genomics (Menlo
Park, CA, USA). The desired 3′UTRs were subcloned in
the pLightSwitch_3UTR vector downstream of the Renilla
luciferase gene. The UTR constructs containing the reference
allele were used as a template to generate point mutations
via site directed mutagenesis. All constructs were verified by
Sanger sequencing. 3′UTR constructs were transfected into
naïve human embryonic kidney (HEK293) and human neu-
roblastoma (SH-SY5Y) cells, which were cultured in DMEM
GlutaMax (Invitrogen, Darmstadt, Germany) media with 10%
FBS (Biochrom, Berlin, Germany) for HEK293 or 15% FBS for
SH-SY5Y cells, with an additional 1% Penicillin/Streptomycin
(Biochrom). The cells were grown in standard conditions (37◦C,
5% CO2). Transfection was carried out in 96-well plates (TPP,
Trasadingen, Switzerland) at a cell confluency of about 50%
using Dharmafect (ThermoScientific) following manufacturer’s
instructions. 50 ng of vector with the desired 3′UTR and 50 nM of
corresponding miRNAmimic or scrambled non-binding miRNA
were co-transfected in the cells per well. The scrambled miRNA
was used as a negative control in combination with all 3′UTR
constructs and in all experiments. After 24 h, HEK293 and SH-
SY5Y cells were collected by freezing the culture plates directly on
dry ice to enhance cell lysis. The plates were then thawed on ice
and the resuspended cell lysates used for the luciferase assays. The
LightSwitch Assay reagents (SwitchGear Genomics) were used
following manufacturer’s instructions. Assay reagents mixed with
the same volume of cell lysate were transferred to a white 96-
well plate (Costar, Washington, D.C., USA). An end point read of
Renilla luciferase intensity values was taken using the POLARStar
Omega (BMG Labtech, Ortenburg, Germany) plate reader with
3 s integration time and 3500 gain per well. Five to seven indepen-
dent experiments per cell line and experimental condition were
performed, using independent transfection mixes and/or differ-
ent cell batches. For each independent experiment, six replicates
were performed.
Statistical analysis of luciferase data
The analysis of the luciferase assay results were performed
using R, an open-source language and environment for statis-
tical computing and graphic (URL: http://www.r-project.org).
We observed no outliers defined as deviating more than three
standard deviations from the mean luciferase luminescence per
experimental condition in each independent experiment. For
each independent experiment, the mean luciferase activity of
the 3′UTR reporter construct (i.e., containing either the refer-
ence or the alternative allele) co-transfected with a functional
miRNA was divided by the baseline mean luciferase activ-
ity of the corresponding reporter construct co-transfected with
the scrambled, non-targeting miRNA as negative control. To
assess binding of the miRNAs to their predicted target sites
irrespective of allele status, normalized luciferase activity of
either 3′UTR reporter construct (i.e., either containing the ref-
erence or the alternative allele) co-transfected with the functional
miRNA was compared to the control condition using the non-
binding miRNA by one-sample t-test (P-values reported for
this analysis are one-tailed). Changes in Renilla gene expres-
sion levels in 3′UTR constructs containing the reference vs.
alternative alleles were assessed based on the t-test statistic for
two independent samples (P-values reported for this analysis are
two-tailed).
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ANALYSIS OF EXPRESSION LEVELS OF miRNA AND mRNA MOLECULES
IN HUMAN POST-MORTEM BRAIN TISSUE
Tissue preparation and RNA extraction
Human brain tissue was collected post-mortem from hippocampi
and frontal cortices from three deceased individuals without
history of neuropsychiatric diseases at the Charité University
Hospital (Berlin, Germany). After collection, brain samples were
stored (at −20◦C) in RNAlater® solution (Applied Biosystems,
Forster City, CA, USA) to avoid degradation. We used the miR-
VANA™ miRNA Isolation Kit (Life Technologies, Darmstadt,
Germany) to extract small and total RNAs from tissue sam-
ples following manufacturer’s instructions. Prior to extraction, all
samples were homogenized using TissueLyser (QIAgen, Hilden,
Germany) by shaking each sample twice in Lysis/Binding buffer
for 2min at 20Hz.
Assessment of miRNA expression levels
The quantification procedure comprises two steps: reverse tran-
scription from RNA to cDNA followed by the amplification
via quantitative PCR (qPCR). Specific primers for reverse tran-
scription and qPCR were based on pre-made TaqMan® Small
RNA Assays (Applied Biosystems). Reverse transcription was
performed on 10 ng RNA using the Taqman® MiRNA Reverse
Transcription Kit according to the manufacturer’s protocol
(Applied Biosystems). The qPCR reaction was conducted using
TaqMan® Small RNA Assays following the manufacturer’s pro-
tocol (Applied Biosystems). In short this entailed: For reverse
transcription 10 ng of the extracted RNA was used in a reac-
tion mix containing Reverse Transcription Buffer, 15mM dNTPs,
50 U/µl MultiScribe™ Reverse Transcriptase, 20 U/µl RNase
Inhibitor, and Primer in a final volume of 15µl. The proto-
col in 384-well format for all reactions was as follows: 16◦C for
30min, 30min at 42◦C and a final step of 85◦C for 5min. The
qPCR reaction was conducted in TaqMan® Universal PCRMaster
Mix II, TaqMan® Small RNA Assay (both Applied Biosystems)
and 1.33µl of the RT-PCR product in a final volume of 20µl.
The cycling protocol was: 10min at 95◦C, 15 s at 95◦C, 60 s at
60◦C for overall 50 cycles. The reactions were run and visualized
on a QuantStudio™ 12 K Flex Real-Time PCR System (Applied
Biosystems).
Assessment of mRNA expression levels
Reverse transcription was performed using the High Capacity
RNA-to-cDNA Kit (Applied Biosystems) on 0.2µg of total RNA
following themanufacturer’s instructions. The reactions were run
on the Thermo Cycler PTC-240 (MJ Research, Waltham, MA,
USA). Expression of the resulting DCP1B cDNA was assessed
via PCR primers 5′-CCAGGGTCTCCTCACAACAT-3′ (forward)
and 5′-TCTTTTTCATGGCTGCTTGA-3′ (reverse). Primers were
designed to lead to a ∼850 bp cDNA amplicon vs. a 6.9 kb gDNA
amplicon. PCR conditions were using 1.5µM of each primer,
approximately 60 ng of cDNA template, 0.25 nM dNTPs, 10mM
MgCl2, 30% Q solution (QIAgen) and 0.25 U Taq polymerase in
a final volume of 10µl. Reactions were carried out in 96-well for-
mat on PTC-240 thermal cyclers at 94◦C (3min), followed by 40
cycles of 94◦C (45 s), 60.5◦C (90 s), and 72◦C (60 s), and a final
extension step of 72◦C (6min). PCR amplicons were visualized
by ethidium bromide stained gel electrophoresis in 1% agarose
(Sigma Aldrich, Taufkirchen, Germany).
EXPRESSION QUANTITATIVE TRAIT LOCUS (eQTL) ANALYSES OF
hsa-miR-138-5p USING NEXT-GENERATION SEQUENCING DATA
eQTL analyses on the potential role of rs9882688 in expression
of hsa-miR-138-5p were performed using next-generation
small RNA sequencing data of peripheral lymphoblas-
toid cell line (LCL) samples generated by the Genetic
European Variation in Health and Disease (GEUVADIS)
consortium (for a description of sequencing methods and
data preparation, see Lappalainen et al., 2013). For the
eQTL analyses here, we downloaded normalized expression
data of hsa-miR-138-5p for four populations of European
descent [i.e., Utah Residents with Northern and Western
European Ancestry (CEU), Finns (FIN), British (GBR), Toscani
(TSI)] as released by the GEUVADIS project database (URL:
http://www.ebi.ac.uk/arrayexpress/files/E-GEUV-2/GD452.Mirna
QuantCount.1.2N.50FN. samplename.resk10.txt). Subject-level
genotypes for rs9882688 in the same individuals were obtained
from the 1000 Genomes database (URL: http://browser.
1000genomes.org/index.html; Abecasis et al., 2010). The result-
ing data set included 333 individuals of European descent with
both hsa-miR-138-5p expression data and rs9882688 genotypes.
Statistical analyses of these data were performed using R. MiRNA
expression values that fell 1.5× the interquartile range (IQR)
below the first quartile or 1.5× the IQR above the third quartile
were defined as outliers and excluded from further analysis
(24 samples). Expression levels of hsa-miR-138-5p showed a
symmetrical, approximately normal distribution in the effective
sample size of 309 individuals [as determined by the Shapiro–
Wilk test implemented in R (P = 0.548) and quantile–quantile
plotting, Supplementary Figure 1]. Subsequent eQTL analyses on
these 309 samples were based on an additive model using linear
regression. Association results were adjusted for sex and popula-
tion of origin. Due to the low frequency of homozygote carriers
of the G allele (n = 2), sensitivity analyses were performed upon
exclusion of those individuals. Statistical significance for these
analyses is expressed as two-tailed P-values.
RESULTS
GWAS OF EPISODIC ANDWORKING MEMORY PERFORMANCE IN
HUMANS
The GWAS analyses on 13 episodic and working memory traits
in up to 1318 individuals from the subgroup of BASE-II partici-
pants aged 60 years or older revealed 28 distinct genomic regions
(or: loci) showing association P-values at 1 × 10−6 or below
(Supplementary Table 2), indicating that at least some of these
are genetically linked to human memory performance. Notably,
these did not include SNPs in WWC1 (KIBRA) or CTNNBL1
(Liu et al., in press), suggesting that the analyzed traits are not
significantly influenced by SNPs in these genes in our study
population. The three most significant findings showed P-values
at or below 1 × 10−7 and were observed with SNPs rs9882688
(P = 7.8 × 10−9 on chr 3p21.32) for trait “WL_save” (part of the
CERAD cognitive battery measuring the proportion of learned
words vs. recalled words), with rs1016365 (P = 9.7 × 10−8 on
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chr 8q13.3) for “ItemItem” (an associative episodic memory task
where probands were asked to learn and recall words irrespec-
tive of their pairing with other words), and with rs113948889
(P = 9.9 × 10−8 on chr 12p13.33) for “TFEUWC” (a spatial
working memory paradigm combined with tasks testing frontal
executive control; see Supplementary Material for more infor-
mation on these and all remaining traits). All of these signals
were flanked by multiple additional SNPs showing P-values at
or below 1 × 10−5 indicating that they do not reflect technical
artifacts (see Supplementary Figures 2–4 for Manhattan and Q–Q
plots for GWAS results of these three traits). Only the signal with
rs9882688 on chr 3 surpassed the threshold for genome-wide sig-
nificance (i.e., P-values at or below 5 × 10−8, a cutoff frequently
used in the context of GWAS, see McCarthy et al., 2008). This
SNP, which itself does not map to any known open reading frame,
is located approx. 20 kb upstream from the 5′ end of miRNA
hsa-mir-138-1 and, thus, potentially within active upstream reg-
ulatory elements of this miRNA. This interpretation is supported
by the fact that rs9882688 is located within an ENCODE DNase
I hypersensitivity cluster and within a known H3K27Ac mark,
two features typically characterizing active regulatory elements
(ENCODE Project Consortium et al., 2012). The second lead-
ing GWAS signal was elicited by SNP rs1016365, which is located
approx. 6 kb 3′ of EYA1 (Homo sapiens eyes absent homolog 1
[Drosophila]) a member of the eyes absent (EYA) family of pro-
teins. The third best associated SNP in our GWAS (rs113948889)
maps to an intron of DCP1B (encoding decapping mRNA 1B),
which is a core component of the mRNA decapping complex, a
key factor in the regulation of mRNA decay. Focusing on these top
GWAS findings, we next performed a number of different in silico
and in vitro experiments to assess their potential role on miRNA
function.
IN SILICO PREDICTIONS OF miRNA-TO-mRNA BINDING AND
POTENTIAL SNP EFFECTS
Using a bioinformatic tool recently developed in our group
(Schilling, 2011, 2013), we predicted the potential role of
the GWAS SNPs on chr 3p21.32, 8q13.3, and 12p13.33 [and
their proxies, i.e., other SNPs in strong LD (r2 ≥ 0.5) and
mapping within ±1Mb] on their potential to interfere with
miRNA-to-mRNA binding. These analyses did not identify any
such effects for the GWAS signals on chr 3 or 8, but several poten-
tially relevant predictions for the memory associated SNPs on chr
12p13.33 (Table 1). All of the SNPs predicted to interfere with
miRNA binding were proxies of rs113948889 with r2 values of
1 and suggested a potential up-regulation of protein expression
conferred by the respective non-reference alleles. The strongest
effect was estimated for rs112215626, predicted to interfere with
the binding of hsa-miR-4775 to the 3′UTR of DCP1B mRNA
(see miRNA-to-mRNA alignment in Figure 1A). The second
strongest effect was estimated for rs1044950, which was predicted
to interfere with the binding of hsa-miR-138-5p to the 3′ UTR
of another DCP1B transcript (Figure 1B). Interestingly, the same
SNP is located within the coding sequence of alternative DCP1B
transcripts where it is predicted to elicit an amino acid change
from alanine to valine at the respective residues (i.e., Ala273Val,
Ala249Val, Ala375Val; Supplementary Table 2). However, this
missense substitution is not predicted to significantly alter protein
function in any of the affectedDCP1B transcripts (Supplementary
Table 3) in silico based on estimates from PolyPhen2 (Adzhubei
et al., 2010) or SIFT (URL: http://sift.bii.a-star.edu.sg/), indicat-
ing that the presumed effects on miRNA-to-mRNA binding may
represent the overarching functional mechanism underlying the
GWAS signal at this locus. Hence, we selected to follow-up the
two leading potentialDCP1BmiRNA SNPs (i.e., rs112215626 and
rs1044950) in vitro.
IN VITRO ASSESSMENT OF SNPs PREDICTED TO AFFECT
miRNA-TO-mRNA BINDING
We conducted luciferase reporter assays in naïve HEK293
cells and SH-SY5Y cells using two different 3′UTR constructs
(containing either the reference or non-reference alleles) of
DCP1B transcripts ENST00000540622 and ENST00000541700
predicted to bind hsa-mir-138-5p and hsa-mir-4775, respec-
tively. In HEK293 cells, co-transfections of the resulting 3′UTR
Renilla vectors and hsa-mir-138-5p showed significant reductions
of luciferase luminescence in comparison to co-transfections
with the non-binding miRNA control (Pone−tailed ≤ 0.000191),
Table 1 | SNPs in LD with memory-associated SNP rs113948889 and predicted to affect miRNA-to-mRNA binding in silico.
GWAS SNP miRNA target CHR BP Distance to miRNA target LD R2 microRNA Target Target
site SNP GWAS SNP site SNP alleles gene transcript
rs113948889 rs112215626 12 2,059,337 44,833 G/A 1 hsa-miR-4775 DCP1B ENST00000540622
rs113948889 rs1044950 12 2,061,982 42,188 T/C 1 hsa-miR-138-5p DCP1B ENST00000541700
rs113948889 rs34730825 12 2,064,602 39,568 C/T 1 hsa-miR-3147 DCP1B ENST00000543381
rs113948889 rs111963484 12 2,102,086 2,084 C/A 1 hsa-miR-4270 DCP1B ENST00000535873
rs113948889 rs111963484 12 2,102,086 2,084 C/A 1 hsa-miR-4441 DCP1B ENST00000535873
rs113948889 rs111963484 12 2,102,086 2,084 C/A 1 hsa-miR-505-5p DCP1B ENST00000535873
rs113948889 rs112637373 12 2,102,271 99 G/T 1 hsa-miR-2909 DCP1B ENST00000535873
rs113948889 rs34730825 12 2,064,602 39,568 C/T 1 hsa-miR-92a-1-5p DCP1B ENST00000543381
Legend: Predicted miRNA target site SNPs in linkage disequilibrium with GWAS SNP rs113948889 listed in descending order of predicted effect on miRNA-to-mRNA
binding. Minor alleles are listed first in "SNP alleles" column. CHR, chromosome; BP, base-pair position on CHR; LD, linkage disequilibrium. Genomic annotations
based on human genome (hg) build 19, transcript IDs according to ENSEMBL v.75. Shaded entries highlight SNPs assessed in vitro.
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FIGURE 1 | Predicted miRNA binding sites in the DCP1B transcripts. (A)
Rs112215626 is located in the seed region of hsa-miR-4775. The alternative
(G) allele of rs112215626 (highlighted in red) may alter binding affinity of
hsa-miR-4775 to the DCP1B 3′UTR and therefore alter protein levels. (B)
Rs1044950 is located in the seed region of hsa-miR-138-5p. The alternative
T allele of the rs1044950 (highlighted in red) may alter binding affinity of
hsa-miR-138-5p to the DCP1B 3′UTR and subsequently alter protein levels.
confirming our predictions that this miRNA binds to the
corresponding 3′UTR in vitro (Figure 2A). Analyses comparing
luciferase luminescence with respect to allele status at rs1044950
revealed a consistent and significant increase in normalized
luciferase expression in constructs containing the minor A-allele
(n = 7, P = 0.0470; Figure 2A). While co-transfection of the
same reporter constructs with hsa-mir-138-5p to SH-SY5Y cells
generally showed similar effects pointing in the same direction,
the difference in luciferase expression between constructs con-
taining the G- vs. A-allele was not statistically significant (n = 9,
P = 0.0866, Figure 2A). Thus, in both cell lines the non-reference
(minor) A-allele of SNP rs1044950 increased luciferase expres-
sion as compared to the reference (major) G-allele by 11.8%
(HEK293) and 10.5% (SH-SY5Y). These findings are in line
with our in silico predictions, which suggested stronger binding
of hsa-mir-138-5p in 3′UTR sequences containing the reference
(G) allele compared to the alternative (A) allele. In contrast,
we did not observe a significant reduction of Renilla expres-
sion upon co-transfecting either reporter construct containing
DCP1B transcript ENST00000540622 with SNP rs112215626 and
hsa-mir-4775 compared to the non-binding miRNA in control
experiments in neither HEK293 nor SH-SY5Y cells (n = 7 and
6, respectively, Pone−tailed ≥ 0.05, Figure 2B). This suggests that
this miRNA, as opposed to hsa-mir-138-5p, does not bind to
the corresponding DCP1B transcript, at least under these exper-
imental conditions. In summary, the results of the luciferase
reporter experiments suggest that SNP rs1044950 elicits allele-
specific effects on the expression of constructs containing the
corresponding DCP1B 3′UTR in the presence of hsa-mir-138-5p
in vitro.
FIGURE 2 | In vitro effects of rs1044950 and rs112215262 on
miRNA-to-mRNA binding and gene expression. The bar charts show the
normalized Renilla luciferase expression in constructs containing DCP1B
3′UTR and corresponding SNP alleles. Depicted are the mean Renilla
luciferase intensities and the standard errors relative to the control
luciferase intensities of the construct co-transfected with the non-targeting
miRNA control (corresponding to the horizontal line): (A) for transcript
ENST00000541700 containing the reference (G) or alternative (A) allele of
rs1044950 and co-transfected with has-miR-138-5p into HEK293 and
SH-SY5Y cells. The relative mean luciferase luminescence of the construct
containing the G and the A allele was 0.585 (±0.0335) and 0.703 (±0.0417)
in HEK293 cells, and 0.880 (±0.0256) and 0.985 (±0.0513) in SH-SY5Y
cells. (B) for transcript ENST00000540622 containing the reference (T) or
alternative (C) allele of rs112215626 and co-transfected with hsa-miR-4775
into HEK293 and SH-SY5Y cells. The relative mean luciferase luminescence
of the construct containing T and the C allele was 0.903 (±0.0692) and
0.931 (±0.0382) in HEK293 cells, and 1.056 (±0.0582) and 1.041 (±0.0185)
in SH-SY5Y cells.
ANALYSIS OF EXPRESSION LEVELS OF hsa-miR-138-5p AND DCP1B
mRNA IN HUMAN POST-MORTEM BRAIN TISSUE
While both hsa-mir-138-1 (Landgraf et al., 2007) and transcripts
of DCP1B (URL: http://human.brain-map.org/) were previously
shown to be expressed in both hippocampus and frontal cortex
in humans, no data exist as to whether this expression actually
occurs at the same time, a prerequisite condition for the inter-
action effects observed in vitro to also be relevant in vivo. To
address this question, we obtained three different post-mortem
hippocampus and frontal cortex specimen, which were profiled
for both miRNA and mRNA expression patterns. qPCR of hsa-
mir-138-5p revealed high expression of this miRNA in both
hippocampal and frontal brain slices for all three individuals
(Figure 3A). Hsa-mir-138-5p expression levels were compara-
ble to those observed for hsa-miR-let-7b, a miRNA ubiquitously
expressed in many human tissues including brain (and used
here as positive control miRNA), in the same specimen (data
Frontiers in Human Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 501 | 6
Schröder et al. MicroRNA-138 and human memory performance
FIGURE 3 | Expression profile of hsa-miR-138-5p and DCP1B in autopsy
brain tissues of three deceased human probands. (A) Amplification plot
of qPCR experiments in three frontal cortices (highlighted in purple) and
three hippocampi (highlighted in green). Hsa-miR-138-5p was expressed in
both frontal cortex (FC) and hippocampus (HC; CT ∼19). One of two NTCs
(non-template control, highlighted in red) showed amplification at CT > 45,
whereas the other NTC did not show any amplification. (B) Ethidium bromide
stained gel electrophoresis in 1% agarose displays the semi-quantitative
levels of DCP1B cDNA (expected and observed at ∼850bp) in post-mortem
human brain tissues. No expression was detected in proband 1 (P1). The
DCP1B cDNA levels were higher in the FC, compared to HC of proband 2
(P2) and proband 3 (P3). (A) gDNA amplicon band (expected and observed
at ∼6.9 kb) could be detected and no band in the NTC.
not shown). Semi-quantitative PCR of DCP1B mRNA in the
same brain samples revealed a more variable expression pat-
tern (Figure 3B). Using this method DCP1B mRNA was only
detectable in two of the three human brain samples (probands 2
and 3 in Figure 3B). Further, in both of these probands DCP1B
mRNA expression levels were higher in frontal cortex as com-
pared to hippocampus (owing to the semi-quantitative nature
of the experiments, these differences could not be assessed for
statistical significance). Regardless of the observed interindivid-
ual and regional expression differences, these experiments clearly
demonstrate that both hsa-mir-138-5p and DCP1B mRNA are
co-expressed simultaneously in both the hippocampi and frontal
cortices in human brain, setting the temporal and spatial stage for
an interaction of these two RNA molecules in vivo.
EXPRESSION QUANTITATIVE TRAIT LOCUS (eQTL) ANALYSES OF
hsa-miR-138-5p USING NEXT-GENERATION SEQUENCING DATA
Although the lead GWAS signal (elicited by rs9882688) identified
in this study was not predicted to interfere with miRNA-to-
mRNA binding in silico, this SNP maps into a potential regula-
tory site 20 kb upstream of miRNA hsa-mir-138-1. The primary
transcript of this miRNA is processed into two different mature
products hsa-mir-138-5p and hsa-mir-138-1-3p, which are both
expressed in humans (Landgraf et al., 2007). Notably, hsa-mir-
138-5p is the same miRNA whose binding to DCP1B is also
potentially affected by the presence of SNP rs1044950, as sug-
gested by the in silico and in vitro experiments outlined above.
Thus, a potential effect of rs9882688 on the expression of hsa-
mir-138-5p could be indicative of a more systematic involvement
of this miRNA in human memory performance. To this end, we
performed eQTL analyses on NGS-based small-RNA sequenc-
ing data in over 300 human lymphoblastoid cell line samples
from the GEUVADIS project (Lappalainen et al., 2013). The
results of these analyses revealed a significant dose-dependent
effect of this SNP on hsa-mir-138-5p expression in these periph-
eral cell lines. Specifically, the presence of the minor G-allele of
rs9882688 was associated with increased hsa-miR-138-5p expres-
sion levels (n = 309, beta = 80.87, standard error [SE] = 23.00,
P-value = 0.000504, Figure 4). This finding was not solely driven
by the two G-allele homozygotes in this dataset as evidenced
by eQTL results after exclusion of these individuals (n = 307,
beta = 77.35, SE = 25.56, P = 0.00270). These data suggest that
the same SNP showing association with episodic memory per-
formance in humans, also significantly correlates with changes in
hsa-mir-138-5p expression in human peripheral cell lines.
DISCUSSION
We investigated the potential role of common DNA sequence
variants associated with humanmemory performance inmiRNA-
mediated regulation of gene expression. A GWAS analysis on
13 memory traits in up to 1318 individuals aged 60 years or
older revealed a number of potential association signals in both
working (rs113948889) and episodic memory (rs9882688 and
rs1016365) domains. Among these were SNPs predicted to be
involved in the expression and function of hsa-mir-138-5p, a
miRNA known to be important in brain development and func-
tion. Specifically, genotypes at SNP rs9882688 (which represented
the lead memory GWAS signal in this study) were shown to cor-
relate significantly with the expression of this hsa-mir-138-5p in
human LCLs using next-generation small-RNA sequencing data.
In addition, we found that SNP rs1044950 (as proxy of another
top GWAS signal) leads to allele-specific changes in the expression
of reporter constructs containing the 3′UTR sequence of DCP1B
transcripts predicted to contain binding sites for hsa-mir-138-
5p in peripheral (HEK293, P = 0.047) and neuronal (SH-SY5Y,
P = 0.0866) human cell lines. Finally, expression profiling of both
hsa-mir-138-5p and DCP1B mRNA in post-mortem brain tis-
sue revealed that both putative interactants are co-expressed in
brain. In summary, in this study various lines of independent evi-
dence converge on the notion that hsa-mir-138-5p may play a
significant role in processes related to human episodic memory
performance.
The data from our study are in line with previous research
on the potential role of mir-138 in mammalian brain function.
For instance, Miska (Miska et al., 2004) showed that mir-138
expression levels increase with age in the developing rat brain
reaching their peak in juvenile and adult rats. Landgraf (Landgraf
et al., 2007) later showed that mir-138 was also highly expressed
in adult human brain samples, including frontal cortex and
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FIGURE 4 | Box plot of the distribution of hsa-miR-138-1-5p expression
levels in lymphoblastoid cell lines dependent on the rs9882688
genotype in 308 individuals of European descent. Horizontal lines
represent median values, boxes represent interquartile ranges, and
whiskers extend to 1.5× the interquartile range; values outside this range
are depicted as circles. Carriers of the rs9882688 G allele showed a
statistically significant (P = 0.000504) increase in hsa-miR-138-1-5p
expression levels.
hippocampus. More recently, mir-138 was identified as part of a
functional screen for dendritic miRNAs that regulate spine mor-
phogenesis in rats (Siegel et al., 2009). In that study, mir-138
was found to act as a negative regulator of dendritic spine size
possibly by tuning the activity of antagonistic signaling that reg-
ulate the actin cytoskeleton in spines. In a review on the same
topic Schratt hypothesized that miR-138-related pathways might
also contribute to long-lasting forms of synaptic plasticity [. . .]”
(Schratt, 2009). Our data, in which we observed multiple con-
verging lines of genetic evidence suggesting a potential role of
hsa-mir-138-5p in episodic memory performance, provide some
first independent support of this hypothesis and extend it to
humans. In addition to DCP1B, hsa-mir-138-5p is predicted to
target a large number of different human transcripts in silico
(ranging between a few hundreds to a few thousands depending
on the prediction algorithm used). In the GWAS results generated
here, genes containing hsa-mir-138-5p targets identified by three
or more of the prediction algorithms show a significant (P <
0.05 based on 100,000 permutations) enrichment for memory-
associated SNPs as compared to genes not targeted by this miRNA
(Supplementary Table 4), further supporting the notion that hsa-
mir-138-5p represents a potential molecular regulator of human
memory function.
The gene DCP1B encodes “decapping mRNA 1B” which is a
core component of the mRNA decapping complex, a key factor
in the regulation of mRNA decay. Decapping and mRNA degra-
dation takes places in P-bodies (processing bodies) (Kulkarni
et al., 2010). Importantly, P-bodies have been suggested to
be one of the predominant sites of miRNA-mediated mRNA
degradation, a process that is inhibited upon depletion of the
decapping DCP1:DCP2 complex (Behm-Ansmant et al., 2006).
Thus, DCP1B and mir-138 function within the same general
pathway, i.e., the degradation ofmRNAs bound bymiRNAs, likely
including those targeted by hsa-mir-138 itself.
While the novel experimental data generated here support the
hypothesis that hsa-mir-138-5p plays an important role in phys-
iological mechanisms involved in human memory performance,
we note the following potential limitations of our findings. First
and foremost, the functional genetic experiments implying a role
of rs1044950 in interfering with miRNA-to-mRNA binding are
based on in vitro experiments using reporter constructs. While
it is tempting to speculate that these effects are also relevant
in vivo, no direct experimental proof of this interpretation cur-
rently exists. In humans, however, this type of evidence is difficult
to come by owing to the fact that molecular mechanisms in the
living human brain cannot be monitored at sufficient resolution
with current technologies. In order for the hypothesized effects
to take place in vivo, both interactants need to be co-expressed
in the same tissue at the same time. Our RNA-profiling exper-
iments using human frontal cortex and hippocampus samples
clearly demonstrate that this is the case for hsa-mir-138-5p and
DCP1B. Second, another conclusion of this study is that SNP
rs9882688 is involved in the regulation of hsa-mir-138-5p expres-
sion. While this could be shown in LCLs, it remains unclear
whether these effects are also relevant in human brain. Third,
linking the GWAS results for rs9882688 to this SNP’s eQTL
effects on hsa-mir-138-5p suggests that the same (i.e., G) allele
increasing miRNA expression is associated with worse episodic
memory performance (indicated by the negative beta-coefficient
in Supplementary Table 1). Increased miRNA abundance is typi-
cally interpreted to lead to an increase in mRNA target repression
and, as a consequence, reduced target gene expression. For SNP
rs1044950, however, the minor (A) allele, associated with worse
memory performance, leads to a decrease in miRNA-to-mRNA
binding in vitro. This latter finding would suggest an increased
target gene expression, i.e., an effect opposite to what can be
expected from the eQTL results with rs9882688. One possible
explanation for these different effect directions is the involvement
of competing endogenous RNAs (ceRNAs). Such ceRNAs were
recently proposed to exist, e.g., generated from transcribed pseu-
dogenes, long noncoding RNAs, or stable RNAs (Salmena et al.,
2011; Helwak et al., 2013). Here they could lead to increased levels
of hsa-mir-138-5p in A-allele carriers of rs1044950, i.e., simi-
lar to what is observed for rs9882688-G. Finally, it needs to be
emphasized that the GWAS results reported here represent pre-
liminary findings that need to be replicated in independent data
sets. However, even if these were to reveal smaller effect estimates
than those reported here (e.g., as a result of the “winner’s curse”;
Kraft, 2008), this should have no bearing on the functional genetic
and expression profiling results of our study. In addition to gener-
ating independent genetic association data, future work will need
to extend our eQTL findings to the CNS, confirm the regulatory
role of hsa-mir-138-5p on endogenous expression of DCP1B and
other target genes and their corresponding proteins (in particu-
lar those potentially involved in human memory function, such
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as WWC1 [KIBRA]), and assess the role of this miRNA on their
putative targets in vivo.
In summary, by combining unbiased genome-wide screening
with extensive in silico modeling, in vitro functional assays, and
gene expression profiling, our study identified hsa-mir-138-5p
as a potential molecular regulator of human memory function.
Future work is needed to assess the relevance of these findings
in vivo and to explore other regulators and targets of this highly
abundant miRNA, in particular their connection to memory and
other cognitive domains.
ACKNOWLEDGMENTS
This work is supported by the German Federal Ministry of edu-
cation and Research [BMBF (grants #16SV5536K, #16SV5537,
#16SV5538, and #16SV5837; previously #01UW0808)], the Max
Planck Society, and a Gottfried Wilhelm Leibniz Award of the
German Research Foundation to Ulman Lindenberger. Julia
Schröder, and Sara Ansaloni were supported by fellowships
of the Max Planck International Research Network on Aging
(MaxNetAging).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fnhum.
2014.00501/abstract
REFERENCES
Abecasis, G. R., Altshuler, D., Auton, A., Brooks, L. D., Durbin, R. M., Gibbs, R.
A., et al. (2010). A map of human genome variation from population-scale
sequencing. Nature 467, 1061–1073. doi: 10.1038/nature09534
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P.,
et al. (2010). A method and server for predicting damaging missense mutations.
Nat. Methods 7, 248–249. doi: 10.1038/nmeth0410-248
Behm-Ansmant, I., Rehwinkel, J., Doerks, T., Stark, A., Bork, P., and Izaurralde, E.
(2006). mRNA degradation by miRNAs and GW182 requires both CCR4:NOT
deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20, 1885–1898.
doi: 10.1101/gad.1424106
Bertram, L., Böckenhoff, A., Demuth, I., Düzel, S., Eckardt, R., Li, S. C., et al.
(2013). Cohort profile: The Berlin Aging Study II (BASE-II). Int. J. Epidemiol.
43, 703–712. doi: 10.1093/ije/dyt018
Betel, D., Koppal, A., Agius, P., Sander, C., and Leslie, C. (2010). Comprehensive
modeling of microRNA targets predicts functional non-conserved
and non-canonical sites. Genome Biol. 11:R90. doi: 10.1186/gb-2010-
11-8-r90
ENCODE Project Consortium., Bernstein, B. E., Birney, E., Dunham, I., Green, E.
D., Gunter, C., et al. (2012). An integrated encyclopedia of DNA elements in the
human genome. Nature 489, 57–74. doi: 10.1038/nature11247
Fillenbaum, G. G., van Belle, G., Morris, J. C., Mohs, R. C., Mirra, S. S.,
Davis, P. C., et al. (2008). Consortium to Establish a Registry for Alzheimer’s
Disease (CERAD): The first twenty years. Alzheimers Dement. 4, 96–109. doi:
10.1016/j.jalz.2007.08.005
Goldberg Hermo, X., Lemos Giráldez, S., and Fañanás Saura, L. (2014). A system-
atic review of the complex organization of human cognitive domains and their
heritability. Psicothema 26, 1–9. doi: 10.7334/psicothema2012.210
Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., and Enright, A. J.
(2006). miRBase: microRNA sequences, targets and gene nomenclature.Nucleic
Acids Res. 34, D140–D144. doi: 10.1093/nar/gkj112
Helwak, A., Kudla, G., Dudnakova, T., and Tollervey, D. (2013). Mapping the
human miRNA Interactome by CLASH reveals frequent noncanonical binding.
Cell 153, 654–665. doi: 10.1016/j.cell.2013.03.043
Kraft, P. (2008). Curses–winner’s and otherwise–in genetic epidemiology.
Epidemiology 19, 649–651; discussion 657–658. doi: 10.1097/EDE.0b013e3181
81b865
Kulkarni, M., Ozgur, S., and Stoecklin, G. (2010). On track with P-bodies. Biochem.
Soc. Trans. 38(Pt 1), 242–251. doi: 10.1042/BST0380242
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A.,
et al. (2007). A mammalian microRNA expression atlas based on small
RNA library sequencing. Cell 129, 1401–1414. doi: 10.1016/j.cell.2007.
04.040
Lappalainen, T., Sammeth, M., Friedländer, M. R., ’t Hoen, P. A., Monlong, J.,
Rivas, M. A., et al. (2013). Transcriptome and genome sequencing uncov-
ers functional variation in humans. Nature 501, 506–511. doi: 10.1038/nature
12531
Li, S. C., Papenberg, G., Nagel, I. E., Preuschhof, C., Schröder, J., Nietfeld, W., et al.
(2013). Aging magnifies the effects of dopamine transporter and D2 receptor
genes on backward serial memory. Neurobiol. Aging 34, 358.e1–358.e10. doi:
10.1016/j.neurobiolaging.2012.08.001
Lill, C. M., Schilling, M., Ansaloni, S., Schröder, J., Jaedicke, M., Luessi, F.,
et al. (2014). Assessment of microRNA-related SNP effects in the 3′ untrans-
lated region of the IL22RA2 risk locus in multiple sclerosis. Neurogenetics 15,
129–134. doi: 10.1007/s10048-014-0396-y
Lindenberger, U., Nagel, I. E., Chicherio, C., Li, S. C., Heekeren, H. R.,
and Bäckman, L. (2008). Age-related decline in brain resources modu-
lates genetic effects on cognitive functioning. Front. Neurosci. 2:2. doi:
10.3389/neuro.01.039.2008
Liu, T., Li, S. C., Papenberg, G., Schröder, J., Roehr, J. T., Nietfeld, W., et al.
(in press). No association between CTNNBL1 and episodic memory perfor-
mance. Transl. Psychiatry.
Marchini, J., and Howie, B. (2010). Genotype imputation for genome-wide associ-
ation studies. Nat. Rev. Genet. 11, 499–511. doi: 10.1038/nrg2796
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J.,
Ioannidis, J. P., et al. (2008). Genome-wide association studies for complex
traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356–369. doi:
10.1038/nrg2344
McClearn, G. E., Johansson, B., Berg, S., Pedersen, N. L., Ahern, F., Petrill, S.
A., et al. (1997). Substantial genetic influence on cognitive abilities in twins
80 or more years old. Science 276, 1560–1563. doi: 10.1126/science.276.53
18.1560
Milnik, A., Heck, A., Vogler, C., Heinze, H. J., de Quervain, D. J., and
Papassotiropoulos, A. (2012). Association of KIBRA with episodic and work-
ing memory: a meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B,
958–969. doi: 10.1002/ajmg.b.32101
Miska, E. A., Alvarez-Saavedra, E., Townsend, M., Yoshii, A., Šestan, N.,
Rakic, P., et al. (2004). Microarray analysis of microRNA expression in the
developing mammalian brain. Genome Biol. 5:R68. doi: 10.1186/gb-2004-
5-9-r68
Morris, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G.,
et al. (1989). The Consortium to Establish a Registry for Alzheimer’s Disease
(CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s
disease. Neurology 39, 1159–1165. doi: 10.1212/WNL.39.9.1159
Papassotiropoulos, A., and de Quervain, D. J. (2011). Genetics of human
episodic memory: dealing with complexity. Trends Cogn. Sci. 15, 381–387. doi:
10.1016/j.tics.2011.07.005
Papassotiropoulos, A., Stephan, D. A., Huentelman, M. J., Hoerndli, F. J., Craig,
D. W., Pearson, J. V., et al. (2006). Common Kibra alleles are associated
with human memory performance. Science 314, 475–478. doi: 10.1126/science.
1129837
Papenberg, G., Li, S. C., Nagel, I. E., Nietfeld, W., Schjeide, B. M., Schröder,
J., et al. (2014). Dopamine and glutamate receptor genes interactively influ-
ence episodic memory in old age. Neurobiol. Aging 35, 1213.e3–1213.e 8. doi:
10.1016/j.neurobiolaging.2013.11.014
Peterson, S. M., Thompson, J. A., Ufkin, M. L., Sathyanarayana, P., Liaw, L., and
Congdon, C. B. (2014). Common features of microRNA target prediction tools.
Front. Genet. 5:23. doi: 10.3389/fgene.2014.00023
Salmena, L., Poliseno, L., Tay, Y., Kats, L., and Pandolfi, P. P. (2011). A ceRNA
hypothesis: The Rosetta Stone of a hidden RNA language? Cell 146, 353–358.
doi: 10.1016/j.cell.2011.07.014
Satoh, J. (2012). Molecular network of microRNA targets in Alzheimer’s disease
brains. Exp. Neurol. 235, 436–446. doi: 10.1016/j.expneurol.2011.09.003
Schilling, M. (2011). In Silico Assessment of the Effects of Single Nucleotide
Polymorphisms on miRNA-mRNA Interactions. Bachelor’s thesis. Department of
Mathematics and Computer Science – FU Berlin, Berlin.
Frontiers in Human Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 501 | 9
Schröder et al. MicroRNA-138 and human memory performance
Schilling, M. (2013). The Role of DNA Sequence Variants Predicted to Alter miRNA-
mRNA Interactions in Disease Pathogenesis. Master’s thesis. Department of
Mathematics and Computer Science – FU Berlin, Berlin.
Schratt, G. (2009). microRNAs at the synapse. Nat. Rev. Neurosci. 10, 842–849. doi:
10.1038/nrn2763
Siegel, G., Obernosterer, G., Fiore, R., Oehmen, M., Bicker, S., Christensen,
M., et al. (2009). A functional screen implicates microRNA-138-dependent
regulation of the depalmitoylation enzyme APT1 in dendritic spine morpho-
genesis. Nat. Cell Biol. 11, 705–716. doi: 10.1038/ncb1876
Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., et al. (2014).
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.
Nucleic Acids Res. 42, D1001–D1006. doi: 10.1093/nar/gkt1229
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 15 April 2014; accepted: 20 June 2014; published online: 11 July 2014.
Citation: Schröder J, Ansaloni S, Schilling M, Liu T, Radke J, Jaedicke M, Schjeide B-
MM,Mashychev A, Tegeler C, RadbruchH, Papenberg G, Düzel S, Demuth I, Bucholtz
N, Lindenberger U, Li S-C, Steinhagen-Thiessen E, Lill CM and Bertram L (2014)
MicroRNA-138 is a potential regulator of memory performance in humans. Front.
Hum. Neurosci. 8:501. doi: 10.3389/fnhum.2014.00501
This article was submitted to the journal Frontiers in Human Neuroscience.
Copyright © 2014 Schröder, Ansaloni, Schilling, Liu, Radke, Jaedicke, Schjeide,
Mashychev, Tegeler, Radbruch, Papenberg, Düzel, Demuth, Bucholtz, Lindenberger,
Li, Steinhagen-Thiessen, Lill and Bertram. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Human Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 501 | 10
